Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169


Is blue dye still required during sentinel lymph node biopsy for breast cancer?

Peek MC, Kovacs T, Baker R, Hamed H, Kothari A, Douek M.

Ecancermedicalscience. 2016 Sep 19;10:674.


Lymph Node Surgery - Stepwise Retirement for the Breast Surgeon?

Landin J, Weber WP.

Breast Care (Basel). 2016 Aug;11(4):282-286.


A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.

Jin X, Jiang YZ, Chen S, Shao ZM, Di GH.

Sci Rep. 2016 Aug 31;6:32585. doi: 10.1038/srep32585.


Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.

Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK.

Ann Surg. 2016 Sep;264(3):413-20. doi: 10.1097/SLA.0000000000001863.


The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer.

Yen TW, Li J, Sparapani RA, Laud PW, Nattinger AB.

Medicine (Baltimore). 2016 Aug;95(31):e4392. doi: 10.1097/MD.0000000000004392.


Sentinel Lymph Nodes for Breast Carcinoma: A Paradigm Shift.

Maguire A, Brogi E.

Arch Pathol Lab Med. 2016 Aug;140(8):791-8. doi: 10.5858/arpa.2015-0140-RA.


In vivo biodistribution studies and ex vivo lymph node imaging using heavy metal-free quantum dots.

Yaghini E, Turner HD, Le Marois AM, Suhling K, Naasani I, MacRobert AJ.

Biomaterials. 2016 Oct;104:182-91. doi: 10.1016/j.biomaterials.2016.07.014.


Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies.

Wang L, Guyatt GH, Kennedy SA, Romerosa B, Kwon HY, Kaushal A, Chang Y, Craigie S, de Almeida CP, Couban RJ, Parascandalo SR, Izhar Z, Reid S, Khan JS, McGillion M, Busse JW.

CMAJ. 2016 Oct 4;188(14):E352-E361.


Sentinel Lymph Node Biopsy Should Be Included with the Initial Surgery for High-Risk Ductal Carcinoma-In-Situ.

Tan EY, Lo ZW, Ang CH, Teo C, Seah MD, Chen JJ, Chan PM.

Int Sch Res Notices. 2014 Oct 29;2014:624185. doi: 10.1155/2014/624185.


Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes.

Mamtani A, Gonzalez JJ, Neo D, Slanetz PJ, Houlihan MJ, Herold CI, Recht A, Hacker MR, Sharma R.

Ann Surg Oncol. 2016 Oct;23(10):3371-8. doi: 10.1245/s10434-016-5368-z.


Impact of Body Mass Index on Clinical Axillary Nodal Assessment in Breast Cancer Patients.

McCartan D, Stempel M, Eaton A, Morrow M, Pilewskie M.

Ann Surg Oncol. 2016 Oct;23(10):3324-9. doi: 10.1245/s10434-016-5330-0.


Coping Strategies of Southern Italian Women Predict Distress Following Breast Cancer Surgery.

De Feudis R, Lanciano T, Rinaldi S.

Eur J Psychol. 2015 May 29;11(2):280-94. doi: 10.5964/ejop.v11i2.908.


Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol.

Park JY, Kim YW, Ryu KW, Nam BH, Lee YJ, Jeong SH, Park JH, Hur H, Han SU, Min JS, An JY, Hyung WJ, Cho GS, Jeong GA, Jeong O, Park YK, Jung MR, Yoon HM, Eom BW.

BMC Cancer. 2016 May 31;16:340. doi: 10.1186/s12885-016-2336-8.


Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.

Cyr AE, Tucker N, Ademuyiwa F, Margenthaler JA, Aft RL, Eberlein TJ, Appleton CM, Zoberi I, Thomas MA, Gao F, Gillanders WE.

J Am Coll Surg. 2016 Aug;223(2):399-407. doi: 10.1016/j.jamcollsurg.2016.04.048.


Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases.

Mamtani A, Patil S, Van Zee KJ, Cody HS 3rd, Pilewskie M, Barrio AV, Heerdt AS, Morrow M.

Ann Surg Oncol. 2016 Oct;23(11):3481-6. doi: 10.1245/s10434-016-5259-3.


How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.

Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, El-Tamer M, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody HS 3rd, Patil S, Morrow M.

Ann Surg Oncol. 2016 Oct;23(11):3467-74. doi: 10.1245/s10434-016-5246-8.


The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.

Karakatsanis A, Christiansen PM, Fischer L, Hedin C, Pistioli L, Sund M, Rasmussen NR, Jørnsgård H, Tegnelius D, Eriksson S, Daskalakis K, Wärnberg F, Markopoulos CJ, Bergkvist L.

Breast Cancer Res Treat. 2016 Jun;157(2):281-94. doi: 10.1007/s10549-016-3809-9.


Management of Axilla in 2015 in Indian Scenario.

Vijaykumar DK, Arunlal M.

Indian J Surg Oncol. 2015 Dec;6(4):435-9. doi: 10.1007/s13193-015-0466-0. Review.


A Scoring System to Predict Arm Lymphedema Risk for Individual Chinese Breast Cancer Patients.

Wang L, Li HP, Liu AN, Wang DB, Yang YJ, Duan YQ, Zhang QN.

Breast Care (Basel). 2016 Feb;11(1):52-6. doi: 10.1159/000443491.


Indocyanine green-based fluorescent angiography in breast reconstruction.

Griffiths M, Chae MP, Rozen WM.

Gland Surg. 2016 Apr;5(2):133-49. doi: 10.3978/j.issn.2227-684X.2016.02.01.

Items per page

Supplemental Content

Support Center